Compound ID | 2229
Class: Drug efflux pump inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Active against Escherichia coli; targets the AcrB component of the AcrAB-TolC transporter |
Propensity to select resistant mutants: | Yes |
Description: | Synthetic compound (pyridylpiperazine); identified from screening assay that synergised activity of pyridomycin; also acts synergistically with chloramphenicol, tetracycline, pyridomycin, erythromycin, and ciprofloxacin; no cytotoxicity towards BALB/3T3 |
Year first mentioned: | 2022 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citations: |
|